Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 6Gastritis 5Lymphoma, B-Cell, Marginal Zone 4Dyspepsia 4Peptic Ulcer 3Lymphoma 3Neoplasms 2Stomach Ulcer 1Skin Neoplasms 1Pseudomyxoma Peritonei 1Neutropenia 1Neoplasms, Plasma Cell 1Metastatic Castration-Resistant Prostate Cancer (mCRPC) 1Lymphoma, Non-Hodgkin 1Lymphoma, Large B-Cell, Diffuse 1Leukemia 1Infections 1Hematologic Neoplasms 1Helicobacter Infections 1Head and Neck Neoplasms 1Glioblastoma 1Gastritis Dyspepsia Helicobacter Pylori Infection Gastric Cancer Peptic Ulcer 1Fever 1Familial primary gastric lymphoma 1Cystectomy 1Chemotherapy Effect 1Brain Neoplasms 1Astrocytoma 1Appendiceal Neoplasms 1Agammaglobulinemia 1

Interventions

Mitomycin 9Oxaliplatin 7Hyperthermic Intraperitoneal Chemotherapy 7Leucovorin 5Irinotecan 5Fluorouracil 4Surveys and Questionnaires 3Cisplatin 3Capecitabine 3dehydroftorafur 2Thalidomide 2Mitozytrex 2Doxorubicin 2Cytoreduction Surgical Procedures 2Biopsy 2surufatinib 1sintilimab 1nintedanib 1irinotecan sucrosofate 1durvalumab 1Yoga 1Watchful Waiting 1Surgical Procedures, Operative 1Specimen Handling 1Referral and Consultation 1Psychiatric Rehabilitation 1Platinum 1Pharmacogenomic Testing 1Palonosetron 1Pafolacianine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Appendiceal Neoplasms × Amoxicillin × Clear all
NCT02387203 2024-11-19

Antibiotic Treatment and Long-term Outcomes of Patients With Pseudomyxoma Peritonei of Appendiceal Origin

Mercy Medical Center

Phase 2 Active not recruiting
80 enrolled
Gastrointestinal

Appendiceal Neoplasms, Pseudomyxoma Peritonei

Data powered by HemOnc (CC BY 4.0) Colophon âš¡